Abcodia had raised £1m in venture funding in May 2011 to make it an impressive winner of VC-backed Business of the Year 2012 (it later raised a £5.3m Series B round led by Cambridge Innovation Capital). The world leader in biomarker validation and discovery service, Abcodia operates in the rapidly growing sector focused on the serach for cancer biomarkers to diagnose cancer earlier. With exclusive access to the largest blood serum bio-bank of its kind in the world.
Angel/VC-backed Business of the Year Finalist 2012: Abcodia
Written By
The Startups Team
